Genzyme, Sanofi negotiations remain in low gear

Biotechnology company Genzyme (NASDAQ: GENZ) may be holding out for more money from suitor Sanofi-Aventis (NYSE: SNY), but  it could find it difficult to persuade investors it is better off on its own. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.